PATENT CLAIM ANALYSIS

Application Number: 15860742
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.

Claim (Index 43):
A vaccine formulation comprising a pharmaceutically acceptable carrier, an adjuvant comprising one or more TLR ligands, and at least one polypeptide comprising any one of SEQ ID NOS: 2, 3, 4 and 5 or an immunogenic fragment thereof, and optionally further comprising a polypeptide comprising SEQ ID NO: 1 or an immunogenic fragment thereof.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 86.0
- Lexical Diversity: 1.14286
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13989119', '12786425', '14360137', '14077676', '15717849']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7498986760662811
- 35 USC 102 Novelty (BERT): 0.561970899549362
- Combined Prediction Score: 0.7311058984145893
- Mean Citation Score: 436.545452
- Max Citation Score: 451.64304
- Similarity Product: 332.93209185207365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test